These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 2565233)

  • 61. Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure.
    Kubo SH; Fox SC; Prida XE; Cody RJ
    Am Heart J; 1985 Nov; 110(5):1032-4. PubMed ID: 3933315
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacokinetics of xamoterol after intravenous and oral administration to volunteers.
    Bastain W; Boyce MJ; Stafford LE; Morton PB; Clarke DA; Marlow HF
    Eur J Clin Pharmacol; 1988; 34(5):469-73. PubMed ID: 2904884
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of the vasodilator prazosin and the selective beta1 agonist prenalterol on rest and exercise haemodynamics in CHF.
    Hutton I; Tweddel AC; Bastian BC; Murray RG
    Acta Med Scand Suppl; 1981; 652():163-8. PubMed ID: 6120615
    [No Abstract]   [Full Text] [Related]  

  • 64. The pharmacology of xamoterol: a basis for modulation of the autonomic control of the heart.
    Snow HM
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):3S-13S. PubMed ID: 2572252
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effects of intravenous carvedilol, a new multiple action vasodilatory beta-blocker, in congestive heart failure.
    DasGupta P; Broadhurst P; Lahiri A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S12-6. PubMed ID: 1721973
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Haemodynamic and metabolic effects of xamoterol in exercising dogs.
    Fischer G; Schneider W; Grohs JG; Ehrendorfer S; Raberger G
    Eur J Pharmacol; 1990 Feb; 177(1-2):19-27. PubMed ID: 2140326
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cardiovascular effects of prenalterol (H133/22) in normal man.
    Scott DH; Arthur GR; Boyes RN; Scott DB
    Br J Clin Pharmacol; 1979 Apr; 7(4):365-70. PubMed ID: 36118
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of xamoterol a new beta-adrenoceptor partial agonist, in patients with angina pectoris.
    Barrios L; Geboers J; Piessens JH; de Geest H
    Eur J Clin Pharmacol; 1986; 29(6):667-71. PubMed ID: 2872055
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy.
    Guazzi MD; Qing LG; Olivari MT; Fiorentini C; Loaldi A; Bartorelli A; Moruzzi P; Polese A
    Acta Med Scand Suppl; 1982; 659():233-50. PubMed ID: 6127892
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of captopril in heart failure complicating acute myocardial infarction and persistence of acute haemodynamic effects in chronic heart failure after 3 years of treatment.
    Mattioli G; Ricci S; Rigo R; Fusaro MT; Cappello C
    Postgrad Med J; 1986; 62 Suppl 1():164-6. PubMed ID: 3534855
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cardiovascular effects of ICI 118,587, a new beta-adrenoceptor partial agonist in man.
    Sasayama S; Yokawa S; Akiyama M; Mikawa M; Sakai O
    Jpn Circ J; 1986 Jul; 50(7):636-43. PubMed ID: 2877103
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure.
    Lapp H; Mitrovic V; Franz N; Heuer H; Buerke M; Wolfertz J; Mueck W; Unger S; Wensing G; Frey R
    Circulation; 2009 Jun; 119(21):2781-8. PubMed ID: 19451356
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Captopril or nifedipine? Comparison of rest and exercise acute effects and long-term therapy in chronic isolated asymptomatic moderate to severe aortic regurgitation.
    Banaszewski M; Rydlewska-Sadowska W; Rubkiewicz S
    J Heart Valve Dis; 1998 Sep; 7(5):488-99. PubMed ID: 9793844
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term studies with xamoterol in heart failure.
    Waller DG
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):53S-58S. PubMed ID: 2572255
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure.
    Elkayam U; Weber L; McKay C; Rahimtoola S
    Am J Cardiol; 1985 Sep; 56(8):560-6. PubMed ID: 4036843
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Selective beta-1-adrenoceptor partial agonist treatment for congestive heart failure.
    Shabetai R
    Cardiology; 1990; 77(5):357-66. PubMed ID: 1981492
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Effect of beta 1-partial agonist(ICI 118-587) on plasma catecholamines level and hemodynamics during exercise in congestive heart failure].
    Sato H; Matsuyama T; Ozaki H; Fukushima M; Matsumoto M
    Kokyu To Junkan; 1984 Nov; 32(11):1159-62. PubMed ID: 6151727
    [No Abstract]   [Full Text] [Related]  

  • 78. Xamoterol in hypertrophic cardiomyopathy: effects on diastolic function and heart rate.
    Gilligan DM; Stewart R; Chan WL; Oakley CM
    Int J Cardiol; 1992 Jun; 35(3):377-86. PubMed ID: 1351887
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acute inotropic stimulation with dopamine in severe congestive heart failure: beneficial hemodynamic effect at rest but not during maximal exercise.
    Maskin CS; Kugler J; Sonnenblick EH; LeJemtel TH
    Am J Cardiol; 1983 Nov; 52(8):1028-32. PubMed ID: 6637818
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure.
    Elkayam U; Weber L; McKay CR; Rahimtoola SH
    Am J Cardiol; 1984 Jul; 54(1):126-31. PubMed ID: 6741802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.